Skip to Main Content

It’s the biotechnology industry’s turn to dazzle Donald Trump — or at least to try — in a meeting at the White House on Monday. Top on the agenda: the hot debate over federal funding for biomedical research.

Given the players — and the politics — fireworks could ensue. Here, five things we’ll be watching:


1. Will Trump ask his guests why they charge so much for drugs?

Vertex Pharmaceuticals CEO Dr. Jeffrey Leiden is coming to the event, as per a guest list obtained by Bloomberg. Why do we mention that? Because Vertex’s cystic fibrosis drug Orkambi has a list price of $259,000 a year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!